2019 EU Drug Markets Report from the EMCDDA and Europol
by
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and European Union Agency for Law Enforcement Cooperation (Europol)
![2019-EU-DRUG-MARKETS-REPORT-FROM-THE-EMCDDA-AND-EUROPOL](/sites/default/files/styles/publications_wide_945/public/2019%2520EU%2520DRUG%2520MARKETS%2520REPORT%2520FROM%2520THE%2520EMCDDA%2520AND%2520EUROPOL.png?itok=cXO3_G2r)
This report provides a strategic and action-oriented analysis of the information available on Europe’s drug market. It uses a broad definition of the illicit drug market, encompassing the illicit production, trafficking, wholesale distribution and sale of controlled substances to the end user. The drug market has wide-ranging impacts on both security and public health, and therefore such a holistic and systemic perspective is important for the effective delivery and monitoring of drug control policy.
Year
2019